Seroprevalence, correlates, and characteristics of undetected coeliac disease in England

Objective: To examine the seroprevalence, correlates, and characteristics of undetected coeliac disease in a large adult population sample in Cambridge, UK. Methods: The Cambridge General Practice Health Study invited individuals from 12 general practices, aged 45–76 years, to attend for a health survey that included a bone density measurement, between 1990 and 1995. A total of 7550 participants’ serum samples were tested for antiendomysial antibody (EMA). Seroprevalence of undetected coeliac disease was based on EMA positivity. Differences between EMA positive and negative participants of various physiological correlates and reported characteristics were estimated by multivariate logistic and linear regression and adjusted for age, sex, social class, and smoking behaviour. Results: The seroprevalence of undetected coeliac disease in this general population sample aged 45–76 was 1.2% (95% confidence interval (CI) 0.9–1.4). EMA positive participants (n=87) were on average slightly lighter by 2.2 kg (p=0.08), were more likely to have reported their general health as being “good or excellent” (odds ratio (OR) 1.76 (95% CI 0.90–3.46)), and were less likely to report being a current smoker (OR for current versus never 0.36 (95% CI 0.14–0.90)) than EMA negative participants. EMA positivity was associated with an 8% reduction in mean serum cholesterol (0.5 mmol/l; p<0.01) and reductions in mean haemoglobin (0.3 g/dl; p<0.01), total protein (1.0 g/l; p<0.05), and corrected serum calcium (0.02 mmol/l; p<0.05). There was an increased risk of osteoporosis in EMA positive participants (OR 3.1 (95% CI 1.3–7.2)) and of mild anaemia (OR 4.6 (95% CI 2.5–8.2)) compared with EMA negative participants. Conclusions: Undetected coeliac disease is likely to affect approximately 1% of the population of England aged 45–76 years, a value similar to several other countries. Those affected report “better health” but they do have an increased risk of osteoporosis and mild anaemia. In contrast, they have a favourable cardiovascular risk profile that may afford protection from ischaemic heart disease and stroke.

[1]  A. Ferguson,et al.  Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. , 1983, British medical journal.

[2]  P. Whorwell,et al.  Death from ischaemic heart-disease and malignancy in adult patients with coeliac disease. , 1976, Lancet.

[3]  M. Bardella,et al.  Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten‐free diet , 1995, Hepatology.

[4]  S. Jabłońska,et al.  IgA anti‐endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease , 1984, The British journal of dermatology.

[5]  E. Smecuol,et al.  Relation between cigarette smoking and Celiac disease: evidence from a case-control study , 2001, American Journal of Gastroenterology.

[6]  J. Sloan,et al.  Prevalence of coeliac disease in Northern Ireland , 1997, The Lancet.

[7]  M. Mäki,et al.  Osteopenia in patients with clinically silent coeliac disease warrants screening , 1999, The Lancet.

[8]  D. Schuppan,et al.  Autoantibodies to tissue transglutaminase as predictors of celiac disease. , 1998, Gastroenterology.

[9]  C. Lee-Elliott,et al.  Adult coeliac disease and cigarette smoking. , 1996, Gut.

[10]  S. Riestra,et al.  Prevalence of Coeliac disease in the general population of northern Spain. Strategies of serologic screening. , 2000, Scandinavian journal of gastroenterology.

[11]  K. Khaw,et al.  Bone Mineral Density at the Hip Predicts Mortality in Elderly Men , 2001, Osteoporosis International.

[12]  D. Sanders,et al.  Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care , 2001, The Lancet.

[13]  M. Färkkilä,et al.  Undiagnosed coeliac disease is common in Finnish adults. , 1998, Scandinavian journal of gastroenterology.

[14]  Markku Peltonen,et al.  High prevalence of undiagnosed coeliac disease in adults: a Swedish population‐based study , 1999, Journal of internal medicine.

[15]  J. Collett,et al.  Adult coeliac disease: Prevalence and clinical significance , 2000, Journal of gastroenterology and hepatology.

[16]  G. Brandi,et al.  High Prevalence of Celiac Disease in Italian General Population , 2001, Digestive Diseases and Sciences.

[17]  A. Zinsmeister,et al.  Cigarette smoking and celiac sprue: a case-control study , 2001, American Journal of Gastroenterology.

[18]  S. Murphy,et al.  Bone mineral density and its relationship to skin colour in Caucasian females , 1995, European journal of clinical investigation.

[19]  P. Whorwell,et al.  DEATH FROM ISCHÆMIC HEART-DISEASE AND MALIGNANCY IN ADULT PATIENTS WITH CŒLIAC DISEASE , 1976, The Lancet.

[20]  M. James,et al.  Endomysial antibody in the diagnosis and management of coeliac disease , 2000, Postgraduate medical journal.

[21]  M. Viola,et al.  Prevalence of celiac disease in argentina: screening of an adult population in the La Plata area , 2001, American Journal of Gastroenterology.

[22]  K. Khaw,et al.  Age-associated bone loss in men and women and its relationship to weight. , 1994, Age and ageing.

[23]  N J Wald,et al.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? , 1994, BMJ.

[24]  I. Dahlbom,et al.  Antibodies Against Human Tissue Transglutaminase and Endomysium in Diagnosing and Monitoring Coeliac Disease , 2002, Scandinavian journal of gastroenterology.

[25]  G. Corazza,et al.  Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. , 1996, Bone.

[26]  J. Olynyk,et al.  High prevalence of coeliac disease in a population‐based study from Western Australia: a case for screening? , 2002, The Medical journal of Australia.